Caspofungin as treatment for Candida glabrata hip infection
Authors:
- T. Lejko-ZupancTLT. Lejko-Zupanc
- E. MožinaEME. Možina
- F. VrevcFVF. Vrevc
- 1 March 2005
- journal article
- other
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (3) , 273-274
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Native Valve Endocarditis due toCandida glabrataTreated without Valvular Replacement: A Potential Role for Caspofungin in the Induction and Maintenance TreatmentClinical Infectious Diseases, 2004
- In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant IsolatesAntimicrobial Agents and Chemotherapy, 2003
- In Vitro Pharmacodynamic Properties of Three Antifungal Agents against PreformedCandida albicansBiofilms Determined by Time-Kill StudiesAntimicrobial Agents and Chemotherapy, 2002
- Efficacies of Fluconazole, Caspofungin, and Amphotericin B inCandida glabrata-Infected p47phox−/−Knockout MiceAntimicrobial Agents and Chemotherapy, 2002
- Delayed Reimplantation Arthroplasty for Candidal Prosthetic Joint Infection: A Report of 4 Cases and Review of the LiteratureClinical Infectious Diseases, 2002
- Late Complications of Candida (Torulopsis) glabrata Fungemia: Description of a PhenomenonScandinavian Journal of Infectious Diseases, 2002
- Candida glabrata Infection After Total Hip ArthroplastyJournal of Infection, 2001
- Candida glabrata Prosthesis Infection Following Pyelonephritis and SepticaemiaScandinavian Journal of Infectious Diseases, 1997
- The effect of amphotericin B, aztreonam, imipenem and cephalosporins on the bone marrow progenitor cell activityJournal of Antimicrobial Chemotherapy, 1991